Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population.
BACKGROUND:HIV-1 and Plasmodium falciparum malaria cause substantial morbidity in Sub-Saharan Africa, especially as co-infecting pathogens. We examined the relationship between presence of P. falciparum DNA in plasma samples and clinical malaria as well as the impact of atazanavir, an HIV-1 protease...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4460081?pdf=render |
| _version_ | 1811215056629661696 |
|---|---|
| author | Marika Orlov Laura M Smeaton Johnstone Kumwenda Mina C Hosseinipour Thomas B Campbell Robert T Schooley |
| author_facet | Marika Orlov Laura M Smeaton Johnstone Kumwenda Mina C Hosseinipour Thomas B Campbell Robert T Schooley |
| author_sort | Marika Orlov |
| collection | DOAJ |
| description | BACKGROUND:HIV-1 and Plasmodium falciparum malaria cause substantial morbidity in Sub-Saharan Africa, especially as co-infecting pathogens. We examined the relationship between presence of P. falciparum DNA in plasma samples and clinical malaria as well as the impact of atazanavir, an HIV-1 protease inhibitor (PI), on P. falciparum PCR positivity. METHODS:ACTG study A5175 compared two NNRTI-based regimens and one PI-based anti-retroviral (ARV) regimen in antiretroviral therapy naïve participants. We performed nested PCR on plasma samples for the P. falciparum 18s rRNA gene to detect the presence of malaria DNA in 215 of the 221 participants enrolled in Blantyre and Lilongwe, Malawi. We also studied the closest sample preceding the first malaria diagnosis from 102 persons with clinical malaria and randomly selected follow up samples from 88 persons without clinical malaria. RESULTS:PCR positivity was observed in 18 (8%) baseline samples and was not significantly associated with age, sex, screening CD4+ T-cell count, baseline HIV-1 RNA level or co-trimoxazole use within the first 8 weeks. Neither baseline PCR positivity (p = 0.45) nor PCR positivity after initiation of antiretroviral therapy (p = 1.0) were significantly associated with subsequent clinical malaria. Randomization to the PI versus NNRTI ARV regimens was not significantly associated with either PCR positivity (p = 0.5) or clinical malaria (p = 0.609). Clinical malaria was associated with a history of tuberculosis (p = 0.006) and a lower BMI (p = 0.004). CONCLUSION:P. falciparum DNA was detected in 8% of participants at baseline, but was not significantly associated with subsequent development of clinical malaria. HIV PI therapy did not decrease the prevalence of PCR positivity or incidence of clinical disease. |
| first_indexed | 2024-04-12T06:16:08Z |
| format | Article |
| id | doaj.art-830ebe19d60747749da1108a651eaf73 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T06:16:08Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-830ebe19d60747749da1108a651eaf732022-12-22T03:44:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01106e012951910.1371/journal.pone.0129519Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population.Marika OrlovLaura M SmeatonJohnstone KumwendaMina C HosseinipourThomas B CampbellRobert T SchooleyBACKGROUND:HIV-1 and Plasmodium falciparum malaria cause substantial morbidity in Sub-Saharan Africa, especially as co-infecting pathogens. We examined the relationship between presence of P. falciparum DNA in plasma samples and clinical malaria as well as the impact of atazanavir, an HIV-1 protease inhibitor (PI), on P. falciparum PCR positivity. METHODS:ACTG study A5175 compared two NNRTI-based regimens and one PI-based anti-retroviral (ARV) regimen in antiretroviral therapy naïve participants. We performed nested PCR on plasma samples for the P. falciparum 18s rRNA gene to detect the presence of malaria DNA in 215 of the 221 participants enrolled in Blantyre and Lilongwe, Malawi. We also studied the closest sample preceding the first malaria diagnosis from 102 persons with clinical malaria and randomly selected follow up samples from 88 persons without clinical malaria. RESULTS:PCR positivity was observed in 18 (8%) baseline samples and was not significantly associated with age, sex, screening CD4+ T-cell count, baseline HIV-1 RNA level or co-trimoxazole use within the first 8 weeks. Neither baseline PCR positivity (p = 0.45) nor PCR positivity after initiation of antiretroviral therapy (p = 1.0) were significantly associated with subsequent clinical malaria. Randomization to the PI versus NNRTI ARV regimens was not significantly associated with either PCR positivity (p = 0.5) or clinical malaria (p = 0.609). Clinical malaria was associated with a history of tuberculosis (p = 0.006) and a lower BMI (p = 0.004). CONCLUSION:P. falciparum DNA was detected in 8% of participants at baseline, but was not significantly associated with subsequent development of clinical malaria. HIV PI therapy did not decrease the prevalence of PCR positivity or incidence of clinical disease.http://europepmc.org/articles/PMC4460081?pdf=render |
| spellingShingle | Marika Orlov Laura M Smeaton Johnstone Kumwenda Mina C Hosseinipour Thomas B Campbell Robert T Schooley Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population. PLoS ONE |
| title | Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population. |
| title_full | Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population. |
| title_fullStr | Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population. |
| title_full_unstemmed | Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population. |
| title_short | Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population. |
| title_sort | presence of plasmodium falciparum dna in plasma does not predict clinical malaria in an hiv 1 infected population |
| url | http://europepmc.org/articles/PMC4460081?pdf=render |
| work_keys_str_mv | AT marikaorlov presenceofplasmodiumfalciparumdnainplasmadoesnotpredictclinicalmalariainanhiv1infectedpopulation AT lauramsmeaton presenceofplasmodiumfalciparumdnainplasmadoesnotpredictclinicalmalariainanhiv1infectedpopulation AT johnstonekumwenda presenceofplasmodiumfalciparumdnainplasmadoesnotpredictclinicalmalariainanhiv1infectedpopulation AT minachosseinipour presenceofplasmodiumfalciparumdnainplasmadoesnotpredictclinicalmalariainanhiv1infectedpopulation AT thomasbcampbell presenceofplasmodiumfalciparumdnainplasmadoesnotpredictclinicalmalariainanhiv1infectedpopulation AT roberttschooley presenceofplasmodiumfalciparumdnainplasmadoesnotpredictclinicalmalariainanhiv1infectedpopulation |